Navigation Links
Cellectis Unveils Its New Corporate Website
Date:9/22/2010

PARIS, Sept. 22 /PRNewswire/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, has announced the launch of its new corporate website. Visitors to this new website are ensured an enhanced usability and information sharing, including more streamlined access to technology and product-related information.

The new Cellectis website focuses on three central themes:

  • Research and Technologies
  • Business Development
  • Investor relations.

In addition to these key areas, the website offers new features and fresh content including:

  • Several specific RSS feeds which enables users to monitor the Company's business in real time, choosing only the subjects they are interested in
  • Social media links (Facebook and Twitter)
  • Downloadable documents that explains Cellectis' technology.

Founded in 1999 by Andre Choulika, PhD and David Sourdive, PhD, Cellectis today has a workforce of over 120 people and 4 subsidiaries, including one located in the U.S. Due to a steady increase in business over the past several months, Cellectis decided to offer its web visitors a showcase that presents the Company' businesses, products and achievements in the most comprehensive manner possible.

Other highlights include the following:

  • A glossary, containing all definitions required to keep up-to-date with Cellectis' activities
  • A graphic library available to qualified journalists, which includes photographs of Cellectis' products and facilities, classified by theme. Journalists need only to register to access and download the files.

The new website can be accessed at: www.cellectis.com.

About Cellectis

Cellectis is a pioneer in the field of genome engineering. The company designs and mar
'/>"/>

SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Taconics Litigation Contesting License Termination By Cellectis Is Dismissed
2. Cellectis bioresearch Establishes The Genome Customization Award (TGCA)
3. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
4. Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
5. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
6. iCyt Unveils New Flow Cytometry Products in Collaboration with Sony at CYTO2010
7. ClearTrial Unveils New Product Release at Partnerships in Clinical Trials Conference 2010
8. Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology
9. Stem Cell Assurance Unveils Physician Network Offering Regenerative Cell Cosmetic and Reconstructive Applications
10. Brooks Instrument Unveils New Web site
11. North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... and difficult to manufacture proteins including biosimilar therapeutics, ... results for the second quarter ended June 30, ... our initial public offering, we have the capital ... derived from our proprietary protein expression platform," stated ...
(Date:8/29/2014)... based on electrons, but one of the most promising ... circuits based on light (photons) instead of electrons. First, ... stream of single photons and control their direction. Researchers ... to achieve this control, but now scientists at the ... stream of photons emitted one at a time and ...
(Date:8/29/2014)... 29, 2014 The global companion ... in 2019. It is expected to grow at ... and was valued at $1.8 billion in 2013, ... Market Research. , For more information regarding analysis ... , The research report, titled “Companion Diagnostics Market ...
(Date:8/29/2014)... 2014 According to a new market report ... orthobiologics market was valued at USD 3,754.6 million in 2012 ... in 2019at a CAGR of 5.9% from 2013 to 2019. ... above is afflicted by bone and joint disorders, and this ... This has and will continue to increase the demand for ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Breakthrough in light sources for new quantum technology 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3
... XIANYANG, China, May 17 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. ... manufacturer of a leading over-the-counter Hepatitis B medicine, Xin,Aoxing Oleanolic ... announced financial results of the first quarter ended March,31, ... revenue increased 66.0% to $12.4 million, -- ...
... 17 Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the ... first quarter of 2010. , ... Soligenix,s revenues for the first quarter of 2010 were approximately ... of 2009. The decreased revenues were primarily a result of decreases in ...
... and MELVILLE, N.Y. May 16 ... Pharmaceuticals, Inc. (Nasdaq: OSIP ), a biotechnology company primarily focused ... medical needs in oncology, diabetes and obesity, today announced that they ... acquire OSI. , , ...
Cached Biology Technology:Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 2Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 3Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 4Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 5Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 6Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 7Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 8Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 9Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 10Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 11Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 12Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results 13Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 2Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 3Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 4Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 5Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc. 2Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc. 3Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc. 4Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc. 5Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc. 6
(Date:8/29/2014)... made some surprising discoveries about the body,s initial ... (SIV), the team found that specialized cells in ... to viral invasion and are the source of ... beta (IL-1β). , Though aimed at the ... gut epithelium that provides a barrier to protect ...
(Date:8/29/2014)... Scientists at the Barshop Institute for Longevity and Aging ... UT Health Science Center at San Antonio, have found ... longest-lived rodent, the naked mole rat. , They ... mole rats protects and alters the activity of the ... , The factor also protects proteasome function in human, ...
(Date:8/29/2014)... little has been known about what genetic changes transform ... scientists, one of whom is a University of Montana ... genes controlling the development of the brain and the ... study was published Aug. 28 in Science ... online at http://www.sciencemag.org/ ., The domestication of animals ...
Breaking Biology News(10 mins):The early cost of HIV 2Factor in naked mole rat's cells enhances protein integrity 2New research reveals how wild rabbits were genetically transformed into tame rabbits 2New research reveals how wild rabbits were genetically transformed into tame rabbits 3
... from the food industry are excellent sources of proteins ... However, at the moment these side streams are mainly ... end up as waste. Coordinated by VTT, the ... containing industrial co-streams) project seeks to enrich several co-stream ...
... is no scientific evidence that low-level electromagnetic field ... causes adverse health effects, according to a report ... the Committee provides advice to authorities about risk ... has assessed the health hazards from low-level electromagnetic ...
... Mass. and COLUMBIA, S.C., Sept. 17, 2012   Eliza Corporation ... engagement management, and BlueCross BlueShield of South Carolina ... rates for BlueCross members increased 45 percent over 2011 ... 2012 program have exceeded expectations in all areas, and ...
Cached Biology News:Food industry's high-quality co-streams used effectively as raw material for new products 2Mobile phones and wireless networks: No evidence of health risk found 2Mobile phones and wireless networks: No evidence of health risk found 3Mobile phones and wireless networks: No evidence of health risk found 4Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 2Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 3Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 4
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
...
Proliferin (C-14)...
... The Turn & Cast submarine gel systems used gasketed ... the gel in the tank. Turn it back and ... For added convenience, each Turn & Cast tray is ... near the edge of the tray and one in ...
Biology Products: